贊宇科技(002637.SZ):滄州贊宇以6797萬元價格競得滄州臨港經濟技術開發區東區兩塊工業用地
格隆匯1月13日丨贊宇科技(002637.SZ)公佈,根據滄州渤海新區自然資源和規劃局國有土地使用權掛牌出讓公吿,公司子公司滄州贊宇分別於2021年10月27日、2021年12月22日參與國有土地使用權競價,並以4105萬元、2692萬元競得摘牌。競得土地的基本情況如下:
(一)地塊一
宗地面積:199995.54平方米;地塊位於:滄州臨港經濟技術開發區東區;土地用途:工業用地;成交價格:4105萬元。
(二)地塊二
宗地面積:131164.71平方米;地塊位於:滄州臨港經濟技術開發區東區,通八路以西,化工四路以北;土地用途:工業用地;成交價格:2692萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.